Journal article · 2025 · Open access
Identifying Pediatric Drug Safety Knowledge Gaps: An Integrated Approach Leveraging Real‐World Data, a Biomedical Knowledge Base, and Postmarketing Surveillance Data
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, 45(10), 667–676 · Published 1 October 2025 · DOI 10.1002/phar.70061
In brief
“Identifying Pediatric Drug Safety Knowledge Gaps: An Integrated Approach Leveraging Real‐World Data, a Biomedical Knowledge Base, and Postmarketing Surveillance Data” is a 2025 journal article by Saurabh Rahurkar and 8 co-authors, published in Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. OpenAlex counts 7 citations as of 19 November 2026. It is open access under a CC BY-NC-ND licence: the full text is free to read at Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy.
- Citations
- 7
- Most cited in
- 2026 (6)
- Field-weighted impact
- 4.99
- References
- 43
- Authors
- 9
Abstract
BACKGROUND: Drug safety has historically been understudied in pediatric populations, rendering them "therapeutic orphans." Pediatric drug indications and dosages are often inferred by extrapolating safety, efficacy, and dosing data from adult studies, leading to widespread off-label use. However, this approach fails to account for age-specific differences in disease pathophysiology and developmental pharmacokinetics (PK). Despite evidence that adverse drug events (ADEs) manifest with greater severity in pediatric populations than in adults, fewer than 50% of drugs have been systematically studied for pediatric use. The lack of robust drug safety data may result in suboptimal or harmful treatment strategies. METHODS: We used a data-driven approach that integrated three databases -including Merative MarketScan claims, the Maternal and Pediatric Precision in Therapeutics (MPRINT) Knowledgebase (including 670,185 pediatric pharmacoepidemiology, PK, and clinical trial publications on 5062 drugs), the United States Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS, a postmarketing safety surveillance database), and FDA drug label data- to identify high-impact target. High-impact targets were defined as drugs that have a high prescription volume, limited safety evidence and high risk of serious ADEs. RESULTS: With 229,550 prescriptions in MarketScan, only 9 studies, and almost 50 high risk serious ADEs benzonatate was identified as a high-impact drug of concern. Serious ADEs included seizure, death, and arrhythmia with proportional reportion ratios (PRRs) ranging from 4.3 to 477.8. CONCLUSION: Approved in 1958, Benzonatate, a nonnarcotic antitussive agent has a limited safety evidence with only nine PE/PK publications in six decades. Moreover, it is frequently prescribed off-label for cough relief despite questionable effectiveness, and high-risk of serious ADEs. Our findings reveal a disconnect between clinical practice and suppporting safety evidence. As such, there is critical need to study the safety of this drug using emerging real-world data for real-world evidence. In summary, this study presents an approach that is systematic, objective, reproducible, and data driven to identify and prioritize drug-ADE combinations with limited evidence.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Rahurkar, S., Ouyang, J., Jonnalagadda, P., Liu, X., Zhang, S., Chiang, C., Wang, L., Shendre, A., & Li, L. (2025). Identifying Pediatric Drug Safety Knowledge Gaps: An Integrated Approach Leveraging Real‐World Data, a Biomedical Knowledge Base, and Postmarketing Surveillance Data. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, 45(10), 667–676. https://doi.org/10.1002/phar.70061
MLA 9
Rahurkar, Saurabh, et al. “Identifying Pediatric Drug Safety Knowledge Gaps: An Integrated Approach Leveraging Real‐World Data, a Biomedical Knowledge Base, and Postmarketing Surveillance Data.” Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, vol. 45, no. 10, 2025, pp. 667–676. https://doi.org/10.1002/phar.70061.
Chicago
Rahurkar, Saurabh, Jiayi Ouyang, Pallavi Jonnalagadda, Xiaofu Liu, Shijun Zhang, Chien‐Wei Chiang, Lei Wang, Aditi Shendre, and Lang Li. 2025. “Identifying Pediatric Drug Safety Knowledge Gaps: An Integrated Approach Leveraging Real‐World Data, a Biomedical Knowledge Base, and Postmarketing Surveillance Data.” Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy 45 (10): 667–676. https://doi.org/10.1002/phar.70061.
Harvard
Rahurkar, S. et al. (2025) ‘Identifying Pediatric Drug Safety Knowledge Gaps: An Integrated Approach Leveraging Real‐World Data, a Biomedical Knowledge Base, and Postmarketing Surveillance Data’, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, 45(10), pp. 667–676. doi:10.1002/phar.70061.
IEEE
S. Rahurkar et al., “Identifying Pediatric Drug Safety Knowledge Gaps: An Integrated Approach Leveraging Real‐World Data, a Biomedical Knowledge Base, and Postmarketing Surveillance Data,” Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, vol. 45, no. 10, pp. 667–676, 2025, doi: 10.1002/phar.70061.
BibTeX
@article{rahurkar2025identifying,
title = {{Identifying Pediatric Drug Safety Knowledge Gaps: An Integrated Approach Leveraging Real‐World Data, a Biomedical Knowledge Base, and Postmarketing Surveillance Data}},
author = {Rahurkar, Saurabh and Ouyang, Jiayi and Jonnalagadda, Pallavi and Liu, Xiaofu and Zhang, Shijun and Chiang, Chien‐Wei and Wang, Lei and Shendre, Aditi and Li, Lang},
journal = {Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy},
year = {2025},
volume = {45},
number = {10},
pages = {667--676},
doi = {10.1002/phar.70061},
url = {https://doi.org/10.1002/phar.70061}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
- drug safety in children
- benzonatate
- adverse drug reactions
- off-label drug use
- antitussive agents
- serious adverse events
- seizures
- cardiac arrhythmias
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Rahurkar, S., Ouyang, J., Jonnalagadda, P., Liu, X., Zhang, S., Chiang, C., Wang, L., Shendre, A., & Li, L. (2025). Identifying Pediatric Drug Safety Knowledge Gaps: An Integrated Approach Leveraging Real‐World Data, a Biomedical Knowledge Base, and Postmarketing Surveillance Data. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, 45(10), 667–676. https://doi.org/10.1002/phar.70061
How many times has this paper been cited?
7 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy: sign in and open the PDF from this page.
Who wrote this paper?
Saurabh Rahurkar, Jiayi Ouyang, Pallavi Jonnalagadda, Xiaofu Liu, Shijun Zhang, Chien‐Wei Chiang, Lei Wang, Aditi Shendre, Lang Li.
What is the DOI of this paper?
10.1002/phar.70061, permanently at https://doi.org/10.1002/phar.70061. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.